Avodart Cost in Alabama 2026: What Dutasteride Actually Costs and How to Pay Less

What Does Dutasteride Actually Cost in Alabama in 2026?

Generic dutasteride 0.5 mg capsules cost Alabama residents roughly $20 to $30 per month at most retail pharmacy chains when a free discount card is applied. Brand-name Avodart carries a list price near $290 per month, a figure almost no cash-paying patient needs to pay given the wide availability of FDA-approved generics [1]. The price spread between brand and generic is one of the sharpest in the 5-alpha reductase inhibitor class.

Dutasteride was originally approved by the FDA in 2001 under the brand name Avodart for the treatment of symptomatic BPH in men with an enlarged prostate [1]. Multiple generic manufacturers entered the U.S. market after patent expiration, and by 2026, over a dozen generic versions are commercially available. That competition drives Alabama retail prices to levels that make the brand-name product financially irrelevant for most patients who pay out of pocket.

To put specific numbers on this: a 30-capsule supply of generic dutasteride 0.5 mg at major Alabama chains (Walgreens, CVS, Walmart, Publix, Costco) runs between $18 and $35 with a GoodRx, RxSaver, or manufacturer savings card applied [2]. Walmart's $4 generic program does not include dutasteride as of early 2026, but Costco's pharmacy typically quotes the lowest cash price among brick-and-mortar options, often around $18 to $22 per month. Publix and Winn-Dixie locations across Alabama trend slightly higher at $25 to $32 [2].

The 90-day supply almost always drops the per-month cost further. Ordering a 90-capsule supply with a discount card at Walmart or Costco in Alabama can bring the per-unit cost below $0.65 per capsule, translating to under $20 per month when annualized [2].

Dutasteride 0.5 mg is taken once daily by mouth. The capsule should be swallowed whole because the drug is absorbed through the mucous membranes of the mouth and throat if chewed or opened, which can cause local irritation [1].

Does Alabama Medicaid Cover Avodart or Generic Dutasteride?

Alabama Medicaid (administered by the Alabama Medicaid Agency) does not cover dutasteride, brand or generic, for BPH or for off-label use in hair loss as of 2026. Medicaid formulary decisions are made at the state level within federal guidelines, and Alabama's preferred drug list (PDL) excludes dutasteride [3]. Finasteride 5 mg, the other 5-alpha reductase inhibitor approved for BPH, is covered by Alabama Medicaid as a preferred agent on the PDL for the BPH indication [3].

That distinction matters clinically. Finasteride and dutasteride share the same pharmacologic class but differ in selectivity: finasteride inhibits only the type II 5-alpha reductase isoenzyme, while dutasteride inhibits both type I and type II [4]. The dual-inhibition profile of dutasteride produces greater and faster suppression of serum dihydrotestosterone (DHT), reaching roughly 90 percent suppression versus approximately 70 percent with finasteride at standard doses [4]. For patients whose prescribers specifically want dual inhibition, the PDL exclusion of dutasteride creates a real access barrier under Alabama Medicaid.

Patients on Alabama Medicaid who require dutasteride over finasteride for a documented clinical reason may request a prior authorization (PA) exception through the Alabama Medicaid Agency's drug exception process [3]. PA approval is not guaranteed and typically requires chart documentation that finasteride was tried and failed or is contraindicated. Without an approved PA, Medicaid will not reimburse dutasteride claims.

Medicare Part D plans operating in Alabama use their own formularies, which vary by plan. Some Part D plans do cover generic dutasteride, typically in Tier 2 or Tier 3, with copays ranging from $10 to $47 per month depending on the plan's cost-sharing structure. Alabama residents enrolled in Medicare should run a formulary check using the Medicare Plan Finder at medicare.gov before choosing a Part D plan if dutasteride is a priority drug [5].

Which Private Insurance Plans Cover Avodart in Alabama?

Most commercial insurance plans sold in Alabama cover generic dutasteride at some tier, but brand-name Avodart is rarely covered without prior authorization because a therapeutically equivalent generic exists [6]. Step therapy requirements, under which a plan requires finasteride to be tried before dutasteride is approved, are common. Alabama's insurance commissioner does not currently require plans to waive step therapy for 5-alpha reductase inhibitors.

Blue Cross and Blue Shield of Alabama, the largest commercial insurer in the state, covers generic dutasteride on its standard formulary in Tier 2 for most commercial plans, with a typical copay of $20 to $45 per 30-day supply depending on the specific plan design [6]. UnitedHealthcare, Cigna, and Aetna plans available through Alabama's ACA marketplace and employer groups generally place generic dutasteride in Tier 2 or Tier 3, producing copays from $15 to $60 [6].

Employer self-funded plans governed by ERISA are not subject to Alabama state insurance regulations and set their own formulary rules. An employee on a self-funded plan should contact their plan's pharmacy benefits manager (PBM), typically Express Scripts, CVS Caremark, or OptumRx, to verify dutasteride coverage and tier placement before filling [6].

If a commercial plan denies coverage and the prescriber documents a clinical reason for dutasteride over finasteride, the patient can initiate an internal appeal followed by an external appeal through the Alabama Department of Insurance if the internal appeal fails [7].

Is Compounded Dutasteride Legal in Alabama?

Compounded dutasteride is legally available in Alabama through state-licensed 503A compounding pharmacies [8]. Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies that produce patient-specific preparations based on a valid prescription from a licensed prescriber [8]. A 503A pharmacy may legally compound dutasteride because it is not on FDA's list of drug products that may not be compounded (the "Demonstrably Difficult to Compound" list or the withdrawn drug list) [9].

Alabama residents typically pay around $40 per month for compounded dutasteride through a 503A pharmacy, compared to $25 for commercially available generic capsules [2]. The higher cost of compounding reflects the labor-intensive process of individual preparation, specialized excipients, and the pharmacy's overhead. Compounded preparations are not FDA-approved and do not carry the same bioavailability and manufacturing quality data as FDA-approved generics [9].

Why would a patient choose compounded dutasteride over a cheaper FDA-approved generic? There are a few valid clinical scenarios. Some providers prescribe compounded topical dutasteride solutions for direct scalp application in androgenetic alopecia, aiming to reduce systemic DHT suppression while delivering drug locally [10]. Oral compounded formulations may also be prepared in doses other than the standard 0.5 mg, such as 0.1 mg or 0.25 mg, for patients whose providers prefer lower-dose titration protocols, particularly in the hair loss setting [10]. Neither topical nor sub-standard-dose dutasteride formulations are FDA-approved; their use is off-label.

503B outsourcing facilities, a different regulatory category, are not the same as 503A pharmacies. A 503B facility may produce bulk compounded drugs without a patient-specific prescription but is subject to FDA Current Good Manufacturing Practice (CGMP) standards [8]. For dutasteride, 503A prescriptions are the operative framework in Alabama because patient-specific compounding is the typical request.

The Alabama State Board of Pharmacy licenses and inspects compounding pharmacies operating in the state. Patients should verify that any 503A pharmacy supplying compounded dutasteride holds a current Alabama pharmacy license and, ideally, PCAB (Pharmacy Compounding Accreditation Board) accreditation [11].

Can Alabama Residents Get Dutasteride Through Telehealth?

Yes. Alabama law permits licensed prescribers to prescribe dutasteride via telehealth without a prior in-person visit, provided the prescriber establishes a valid patient-provider relationship through a synchronous audio-video encounter [12]. Dutasteride is a Schedule-exempt oral prescription medication, not a controlled substance, so it does not require the additional prescribing restrictions that apply to, for example, testosterone or GLP-1 injectable medications.

Several telehealth platforms operating in Alabama specifically offer dutasteride prescribing for hair loss. After an online consultation, the prescriber sends the prescription electronically to either a retail pharmacy of the patient's choice or to a compounding pharmacy. The patient pays the pharmacy directly. Most hair-loss telehealth visits in Alabama cost $30 to $75 for the initial consultation, with follow-up visits typically free or under $25 [12].

Alabama's Telehealth Act (Ala. Code Section 34-24-701 et seq.) governs these encounters. The law requires that telemedicine providers be licensed in Alabama or hold a valid Alabama telemedicine certificate [12]. Patients using out-of-state telehealth platforms should confirm that the prescribing physician holds an active Alabama medical license or the Alabama-specific telemedicine authorization before accepting a prescription, since out-of-state prescribers without proper licensure cannot legally prescribe to Alabama patients [12].

Clinical Evidence Supporting Dutasteride for BPH and Hair Loss

Dutasteride's FDA approval for BPH rests on the CombAT trial and the ARIA clinical program, which together enrolled thousands of men with symptomatic BPH and demonstrated statistically significant reductions in prostate volume, symptom scores, and the risk of acute urinary retention [13]. The 4-year CombAT trial (N = 4,844) showed that combination therapy with dutasteride 0.5 mg plus tamsulosin 0.4 mg reduced the relative risk of acute urinary retention or BPH-related surgery by 65.8 percent compared with tamsulosin alone (P<0.001) [13].

For androgenetic alopecia, dutasteride is not FDA-approved but is approved in South Korea and Japan for male pattern hair loss. Eun et al. (J Am Acad Dermatol, 2010, N = 153) showed that dutasteride 0.5 mg daily produced significantly greater increases in target-area hair counts at 24 weeks compared with finasteride 1 mg daily, with a mean difference of 12.2 hairs per cm2 favoring dutasteride (P<0.001) [14]. Hair-count superiority was also demonstrated for dutasteride 0.1 mg and 0.5 mg versus placebo at 24 weeks in the same trial [14].

A 2019 systematic review and meta-analysis published in JAMA Dermatology (Gupta et al.) evaluated 5-alpha reductase inhibitors for androgenetic alopecia across 23 randomized controlled trials and found that dutasteride produced numerically greater hair density improvement than finasteride, though head-to-head evidence remained limited [15]. The authors noted that the available evidence supported dutasteride's off-label use for male pattern hair loss when finasteride had failed or when a more potent DHT suppressor was clinically indicated [15].

The table below summarizes the key cost and access variables for Alabama residents in 2026 and can serve as a clinical reference during prescribing discussions.

Dutasteride Access Framework for Alabama Prescribers and Patients (2026)

| Pathway | Monthly Cost | Coverage / Legal Status | Notes | |---|---|---|---| | Brand Avodart (GSK) | ~$290 | Rarely covered commercially; not on AL Medicaid PDL | GSK savings card may reduce to $0 for eligible commercial patients | | Generic dutasteride 0.5 mg (retail + discount card) | $20 to $35 | Available at all AL retail pharmacies | Best value for most cash-pay patients | | Generic dutasteride (Part D) | $10 to $47 copay | Covered by most Part D plans in AL (Tier 2-3) | Run Medicare Plan Finder check | | Compounded oral dutasteride (503A) | ~$40 | Legal in AL; not FDA-approved | Used for non-standard doses; requires AL-licensed 503A pharmacy | | Compounded topical dutasteride (503A) | ~$50 to $80 | Legal in AL; not FDA-approved | Off-label scalp application for hair loss | | Alabama Medicaid | Not covered | Not on PDL; PA possible but rarely approved | Finasteride (BPH) is covered as preferred agent |

GSK Savings Cards and Generic Manufacturer Discount Programs in Alabama

GSK, the original manufacturer of Avodart, offers a savings card for commercially insured patients that may reduce the brand-name cost to as low as $0 per month for eligible patients [16]. The GSK savings card is not valid for patients using Alabama Medicaid, Medicare, or any other federal or state government insurance program [16]. Patients pay nothing at the pharmacy and GSK covers the remainder up to program limits, subject to eligibility verification at gsksavingscards.com.

Generic manufacturers do not typically offer savings cards because their cash prices are already low. Instead, free discount programs through GoodRx, RxSaver, NeedyMeds, or the Partnership for Prescription Assistance produce the $20 to $25 per month pricing seen at Alabama retail pharmacies [2]. These programs are available to any Alabama resident regardless of insurance status and do not require enrollment or income verification. The coupon is printed or loaded to a phone and presented at the pharmacy counter at pickup.

NeedyMeds also maintains a database of patient assistance programs (PAPs) for uninsured or underinsured patients who cannot afford even generic pricing [17]. GSK's PAP for Avodart (branded) provides free medication to qualifying uninsured patients with household incomes below 400 percent of the federal poverty level [17]. As a practical matter, generic dutasteride at $20 to $25 per month is more accessible for most low-income Alabama patients than navigating a PAP enrollment process, but the PAP route is worth pursuing for patients who cannot afford any out-of-pocket cost.

Side Effects, Monitoring, and Alabama Prescribing Considerations

Dutasteride carries FDA-required class labeling covering sexual side effects and a small but statistically significant signal for high-grade prostate cancer observed in the REDUCE trial (N = 8,231), in which dutasteride 0.5 mg daily over 4 years was associated with a higher rate of Gleason 8 to 10 prostate cancer compared with placebo (1.0 percent vs. 0.5 percent, P = 0.003), though total prostate cancer incidence was reduced [18]. This finding led to an FDA label update and should be part of the informed consent process for any dutasteride prescription [1, 18].

Common side effects include decreased libido, erectile dysfunction, ejaculation disorders, and gynecomastia. These effects are dose-dependent and partially reversible upon discontinuation [1]. Because dutasteride has a long elimination half-life of approximately 3 to 5 weeks, side effects may persist for several months after stopping the drug [1].

Alabama prescribers should document pre-treatment PSA values because dutasteride reduces PSA by approximately 50 percent after 6 months of therapy [19]. A PSA measured during dutasteride therapy should be doubled to estimate the unmedicated baseline for prostate cancer screening purposes, per guidance from the American Urological Association [19]. Failure to account for this effect can mask a rising PSA that signals prostate malignancy.

Dutasteride is Category X in pregnancy. The drug is absorbed through the skin; women who are pregnant or may become pregnant must not handle crushed or broken dutasteride capsules [1]. Alabama prescribers writing dutasteride for men in households with women of childbearing potential should counsel on this risk explicitly.